Avenir Wellness Solutions, Inc. (AVRW)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Feb 12, 2026, 9:31 AM EST
Avenir Wellness Solutions Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| 2.05 | 4.35 | 4.9 | 6.08 | 2.05 | 0.62 | |
Revenue Growth (YoY) | -50.53% | -11.21% | -19.45% | 196.34% | 229.21% | 6.68% |
Cost of Revenue | 0.61 | 1.24 | 1.56 | 1.75 | 1.08 | 0.23 |
Gross Profit | 1.44 | 3.11 | 3.34 | 4.33 | 0.98 | 0.39 |
Selling, General & Admin | 4.44 | 9.07 | 10.17 | 14.19 | 11.37 | 9.82 |
Research & Development | - | - | - | - | 2.79 | 2.31 |
Operating Expenses | 4.5 | 9.12 | 11.73 | 16.5 | 14.15 | 12.13 |
Operating Income | -3.06 | -6.01 | -8.39 | -12.17 | -13.18 | -11.74 |
Interest Expense | -0.05 | -0.06 | -0.47 | -0.64 | -2.47 | -4.11 |
Interest & Investment Income | 0.01 | 0.05 | 0.05 | 0.06 | 0.04 | 0.06 |
Other Non Operating Income (Expenses) | - | - | 0.03 | - | 0.09 | -0.05 |
EBT Excluding Unusual Items | -3.09 | -6.02 | -8.77 | -12.75 | -15.52 | -15.84 |
Merger & Restructuring Charges | - | - | - | - | - | -0.3 |
Impairment of Goodwill | - | - | -4.69 | - | - | - |
Gain (Loss) on Sale of Investments | -0.15 | -0.15 | -0.07 | -0.35 | - | - |
Gain (Loss) on Sale of Assets | - | - | -0.02 | -0.04 | - | 0.08 |
Asset Writedown | - | - | -5.76 | - | - | - |
Other Unusual Items | 0.49 | 2.72 | 0.82 | 4.56 | -15.1 | -5.32 |
Pretax Income | -2.75 | -3.44 | -18.5 | -8.58 | -30.62 | -21.37 |
Income Tax Expense | 0.01 | 0 | 0.04 | - | - | - |
Earnings From Continuing Operations | -2.76 | -3.44 | -18.54 | -8.58 | -30.62 | -21.37 |
Earnings From Discontinued Operations | - | - | -6.97 | -4.61 | - | - |
Net Income to Company | -2.76 | -3.44 | -25.51 | -13.19 | -30.62 | -21.37 |
Minority Interest in Earnings | - | - | - | - | - | 0.01 |
Net Income | -2.76 | -3.44 | -25.51 | -13.19 | -30.62 | -21.36 |
Net Income to Common | -2.76 | -3.44 | -25.51 | -13.19 | -30.62 | -21.36 |
Shares Outstanding (Basic) | 77 | 72 | 70 | 62 | 47 | 35 |
Shares Outstanding (Diluted) | 77 | 72 | 70 | 62 | 47 | 35 |
Shares Change (YoY) | 7.36% | 2.69% | 12.60% | 31.80% | 36.96% | 38.16% |
EPS (Basic) | -0.04 | -0.05 | -0.36 | -0.21 | -0.65 | -0.62 |
EPS (Diluted) | -0.04 | -0.05 | -0.36 | -0.21 | -0.65 | -0.62 |
Free Cash Flow | -1.55 | -3.85 | -10.07 | -4.32 | -10.4 | -8.51 |
Free Cash Flow Per Share | -0.02 | -0.05 | -0.14 | -0.07 | -0.22 | -0.25 |
Gross Margin | 70.27% | 71.52% | 68.20% | 71.22% | 47.54% | 62.92% |
Operating Margin | -149.53% | -138.28% | -171.28% | -200.18% | -642.57% | -1883.63% |
Profit Margin | -134.82% | -79.23% | -521.02% | -217.06% | -1492.98% | -3429.05% |
Free Cash Flow Margin | -75.65% | -88.45% | -205.76% | -70.99% | -506.83% | -1365.97% |
EBITDA | -2.98 | -5.94 | -6.91 | -9.84 | -12.26 | -11.16 |
EBITDA Margin | -145.72% | -136.60% | -141.03% | -161.89% | - | - |
D&A For EBITDA | 0.08 | 0.07 | 1.48 | 2.33 | 0.92 | 0.58 |
EBIT | -3.06 | -6.01 | -8.39 | -12.17 | -13.18 | -11.74 |
EBIT Margin | -149.53% | -138.28% | -171.28% | -200.18% | - | - |
Revenue as Reported | 2.05 | 4.35 | 4.9 | 6.08 | 2.05 | 0.62 |
Advertising Expenses | - | - | - | - | 1.1 | 0.5 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.